| __timestamp | Blueprint Medicines Corporation | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 13673000 |
| Thursday, January 1, 2015 | 48588000 | 14358000 |
| Friday, January 1, 2016 | 81131000 | 12203000 |
| Sunday, January 1, 2017 | 144687000 | 18125000 |
| Monday, January 1, 2018 | 243621000 | 17071000 |
| Tuesday, January 1, 2019 | 331450000 | 20018000 |
| Wednesday, January 1, 2020 | 326860000 | 32788000 |
| Friday, January 1, 2021 | 601033000 | 44966000 |
| Saturday, January 1, 2022 | 477419000 | 311681000 |
| Sunday, January 1, 2023 | 427720000 | 77707000 |
| Monday, January 1, 2024 | 341433000 |
Unleashing the power of data
In the competitive landscape of biotechnology and pharmaceuticals, innovation is the key to success. Blueprint Medicines Corporation and Lantheus Holdings, Inc. have been at the forefront of this race, each with a unique approach to research and development (R&D) investments. Over the past decade, Blueprint Medicines has consistently outpaced Lantheus Holdings in R&D spending, with an average annual investment nearly five times greater. In 2021, Blueprint Medicines reached its peak, allocating approximately 60% more to R&D than in previous years. Meanwhile, Lantheus Holdings has shown a steady increase, with a notable spike in 2022, where their R&D expenses surged by over 600% compared to 2014. This data highlights the strategic priorities of these companies and underscores the importance of R&D in driving innovation and growth in the biotech sector.
R&D Spending Showdown: Gilead Sciences, Inc. vs Blueprint Medicines Corporation
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Alnylam Pharmaceuticals, Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Blueprint Medicines Corporation and Mesoblast Limited
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.